IKARIAN CAPITAL, LLC – Relmada Therapeutics, Inc. Transaction History
IKARIAN CAPITAL, LLC portfolio value:
$28.70M
portfolio value
Relmada Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | put | Increase | +174.64% | 493K shares | 23.34M | $37.02 | 775.3K |
| Q3 2022 | call | Increase | +158.43% | 475.3K shares | 23.00M | $37.02 | 775.3K |
| Q2 2022 | call | Increase | 0.00% | 300K shares | 5.69M | $18.99 | 300K |
| Q2 2022 | put | Increase | 0.00% | 282.3K shares | 5.36M | $18.99 | 282.3K |
| Q2 2022 | share | Decrease | -100.00% | -21.80K shares | -588K | $18.99 | 0 |
| Q1 2022 | share | Increase | +5.10% | 1.05K shares | 121K | $26.99 | 21.80K |
| Q4 2021 | share | 0.00% | 0 shares | -77K | $21.71 | 20.74K | |
| Q3 2021 | share | Decrease | -93.09% | -279.46K shares | -9.06M | $26.21 | 20.74K |
| Q3 2021 | call | Decrease | -100.00% | -203.4K shares | -6.51M | $26.21 | 0 |
| Q2 2021 | share | Increase | +3.45% | 10K shares | -609K | $32.01 | 300.20K |
| Q2 2021 | call | Increase | +2.94% | 5.8K shares | -447K | $32.01 | 203.4K |
| Q1 2021 | share | Increase | 0.00% | 290.20K shares | 10.21M | $35.21 | 290.20K |
| Q1 2021 | call | Increase | 0.00% | 197.6K shares | 6.95M | $35.21 | 197.6K |
| Q2 2020 | share | Decrease | -100.00% | -55.17K shares | -1.88M | $44.75 | 0 |
| Q1 2020 | share | Increase | 0.00% | 55.17K shares | 1.88M | $34.11 | 55.17K |